An article by SmartTRAK shows that Cellular Tissue Products (CTPs) / Skin Substitutes in the Physician Office and Mobile environment grew by over $5 Billion between 2021 and 2024 compared to only $1 Billion in all other care settings combined. The U.S. CTP/skin substitute market is led by Extremity Care which has >18% of the market, followed by BioLab Sciences which has >11% of the market. More detailed insights are available by subscription from SmartTRAK, but you can access additional insights free of charge on the SmartTRAK blog.
Caroline
Dr. Fife is a world renowned wound care physician dedicated to improving patient outcomes through quality driven care. Please visit my blog at CarolineFifeMD.com and my Youtube channel at https://www.youtube.com/c/carolinefifemd/videos
The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.
